Differences in susceptibility of HT‐29 and A549 cells to statin‐induced toxicity: An investigation using high content screening. Issue 4 (4th January 2021)

• Record Type: Journal Article
• Authors: Wei, Guilin; Xue, Lijuan; Zhu, Yadi; Qian, Xingkai; Zou, Liwei; Jin, Qiang; Wang, Dandan; Ge, Guangbo
• Is Part Of: Journal of biochemical and molecular toxicology. Volume 35:Issue 4(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-01-04
• Subjects: cytotoxicity -- HCS -- mitochondrial damage -- statins -- susceptibility; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Toxicology -- Periodicals; 574
• DOI: 10.1002/jbt.22699
• Languages: English
• ISSNs: 1095-6670

Abstract

Abstract: Statins are a group of hydroxymethylglutaryl coenzyme A reductase inhibitors that are used in the treatment of cardiovascular diseases. However, statins have been found to be cytotoxic, and many unexpected side effects have been reported in clinical applications. The susceptibilities of different cell lines toward statins are diverse, and the mechanisms of cytotoxicity remain unknown. Therefore, the present study aimed to investigate differences in the susceptibility to and mechanisms of statin‐induced cytotoxicity in two cell lines, HT‐29 and A549, using a high content screening‐based multiparametric toxicity assay panel. We found that the two cell types exhibited differing susceptibilities to the cytotoxic effects of the different statins. Additionally, the cytotoxicity was inconsistent between different statins in the two cell lines. Four statins with strong cytotoxicity decreased the viability of HT‐29 cells via the mitochondrial pathway, as evidenced by decreased mitochondrial membrane potential, and elevated mitochondrial mass, calcium release and cell apoptosis, and reactive oxygen species. In contrast, these four statins only induced a decrease in the mitochondrial membrane potential in A549 cells. The above results provide an objective reason for future evaluations of cytotoxic differences in cell types and the underlying mechanisms of cytotoxicity in different statins, and provide a good scientific basis for further research on countermeasures against statin‐induced cell injuries.